Impact of pulmonary interstitial lesions on efficacy and prognosis of EGFR-TKI-treated advanced non-small cell lung cancers

BACKGROUND: This study aimed to assess the impact of pre-existing pulmonary interstitial lesions (PIL) on the efficacy and prognosis of patients with epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer (NSCLC) treated with EGFR tyrosine kinase inhibitor (TKI). METHODS: Patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiang-Yan, Cao, Rui, Guo, Yi-Jia, Zhen, Yan-Hua, Zheng, Jia-He, Huang, Le-Tian, Zhang, Shu-Ling, Jing, Wei, Sun, Li, Zhao, Jian-Zhu, Han, Cheng-Bo, Ma, Jie-Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138988/
https://www.ncbi.nlm.nih.gov/pubmed/32274151
http://dx.doi.org/10.21037/jtd.2019.12.128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138988/
https://www.ncbi.nlm.nih.gov/pubmed/32274151
http://dx.doi.org/10.21037/jtd.2019.12.128

Ejemplares similares